Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000558·Relay Therapeutics, Inc.
Schedule 13G ownership disclosure
Relay Therapeutics Inc
Common Stock · CUSIP: 75943R102
Event date: 2025-03-31
- Filing-level shares
- 12,105,420
- Percent of class
- 7.14%
- The Vanguard Group
Shares: 12,105,420 · Class: 7.14%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000558
- Form type
- SCHEDULE 13G/A
- Filer
- Relay Therapeutics, Inc.
- CIK
- CIK 1812364
- Filed
- Apr 30, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership